JP2009530393A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530393A5
JP2009530393A5 JP2009501562A JP2009501562A JP2009530393A5 JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5 JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009501562 A JP2009501562 A JP 2009501562A JP 2009530393 A5 JP2009530393 A5 JP 2009530393A5
Authority
JP
Japan
Prior art keywords
monocyclic
compound
alkyl
bicyclic
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009501562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/007146 external-priority patent/WO2007111954A2/en
Publication of JP2009530393A publication Critical patent/JP2009530393A/ja
Publication of JP2009530393A5 publication Critical patent/JP2009530393A5/ja
Withdrawn legal-status Critical Current

Links

JP2009501562A 2006-03-23 2007-03-22 プリン化合物およびその使用方法 Withdrawn JP2009530393A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78501406P 2006-03-23 2006-03-23
US78509206P 2006-03-23 2006-03-23
US78509306P 2006-03-23 2006-03-23
US78509406P 2006-03-23 2006-03-23
PCT/US2007/007146 WO2007111954A2 (en) 2006-03-23 2007-03-22 Purine compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009530393A JP2009530393A (ja) 2009-08-27
JP2009530393A5 true JP2009530393A5 (https=) 2010-05-06

Family

ID=38541654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009501562A Withdrawn JP2009530393A (ja) 2006-03-23 2007-03-22 プリン化合物およびその使用方法

Country Status (10)

Country Link
US (1) US20070238694A1 (https=)
EP (1) EP1996020A4 (https=)
JP (1) JP2009530393A (https=)
KR (1) KR20080110816A (https=)
AU (1) AU2007229463A1 (https=)
BR (1) BRPI0709124A2 (https=)
CA (1) CA2643503A1 (https=)
IL (1) IL193693A0 (https=)
MX (1) MX2008012185A (https=)
WO (1) WO2007111954A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117910A2 (en) * 2004-05-26 2005-12-15 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
MX2007003271A (es) * 2004-09-20 2007-06-05 Inotek Pharmaceuticals Corp Derivados de purina y metodos de uso de los mismos.
EA015683B1 (ru) * 2005-11-30 2011-10-31 Инотек Фармасьютикалз Корпорейшн Производные пурина и способы их применения
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2774704A1 (en) * 2009-10-26 2011-05-05 Inotek Pharmaceuticals Corporation Ophthalmic formulation and method of manufacture thereof
SG182285A1 (en) 2010-01-11 2012-08-30 Inotek Pharmaceuticals Corp Combination, kit and method of reducing intraocular pressure
EA201290958A1 (ru) 2010-03-26 2013-04-30 Инотек Фармасьютикалз Корпорейшн Способ снижения внутриглазного давления у людей с применением n6-циклопентиладенозина (cpa), производных cpa или их пролекарств
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
BR112014018413A8 (pt) * 2012-01-26 2017-07-11 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de metila [(2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-diidroxitetraidrofuran-2-il)] e processos de preparação do mesmo
US20140275128A1 (en) * 2013-03-15 2014-09-18 Inotek Pharmaceuticals Corporation Method of providing ocular neuroprotection
CA2903114A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
US20040063658A1 (en) * 2002-05-06 2004-04-01 Roberts Christopher Don Nucleoside derivatives for treating hepatitis C virus infection
WO2005117910A2 (en) * 2004-05-26 2005-12-15 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
MX2007003271A (es) * 2004-09-20 2007-06-05 Inotek Pharmaceuticals Corp Derivados de purina y metodos de uso de los mismos.

Similar Documents

Publication Publication Date Title
JP2009530393A5 (https=)
JP2006143751A5 (https=)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2009504763A5 (https=)
JP2005518350A5 (https=)
JP2013509411A5 (https=)
JP2013508279A5 (https=)
WO2012138894A4 (en) Hsp90 inhibitors
JP2003506354A5 (https=)
JP2018518537A5 (https=)
JP2004531517A5 (https=)
JP2009513658A5 (https=)
JP2005501120A5 (https=)
JP2013532726A5 (https=)
JP2010501584A5 (https=)
JP2008545793A5 (https=)
JP2000256194A (ja) 核内レセプタ作動薬およびその効果増強剤
JP2017526677A5 (https=)
JP2019515908A5 (https=)
JP2006507220A5 (https=)
JP2007501779A5 (https=)
CA2303815A1 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2010522710A5 (https=)
JP2007515476A5 (https=)